NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 169 filers reported holding NOVAVAX INC in Q1 2015. The put-call ratio across all filers is 2.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $111,000 | -2.6% | 60,532 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $114,000 | +40.7% | 60,532 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $81,000 | -36.2% | 60,532 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $127,000 | +69.3% | 60,532 | 0.0% | 0.00% | – |
Q4 2017 | $75,000 | +8.7% | 60,532 | 0.0% | 0.00% | – |
Q3 2017 | $69,000 | -1.4% | 60,532 | 0.0% | 0.00% | -100.0% |
Q2 2017 | $70,000 | -9.1% | 60,532 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $77,000 | +1.3% | 60,532 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $76,000 | -39.7% | 60,532 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $126,000 | -71.4% | 60,532 | 0.0% | 0.00% | -75.0% |
Q2 2016 | $440,000 | +41.0% | 60,532 | 0.0% | 0.00% | +33.3% |
Q1 2016 | $312,000 | -36.6% | 60,532 | +3.3% | 0.00% | -25.0% |
Q4 2015 | $492,000 | +18.8% | 58,595 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $414,000 | -36.6% | 58,595 | 0.0% | 0.00% | -20.0% |
Q2 2015 | $653,000 | +34.6% | 58,595 | 0.0% | 0.01% | +25.0% |
Q1 2015 | $485,000 | – | 58,595 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
Bellevue Group AG | 325,000 | $410,000 | 0.08% |
Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |